Back
Day Range
$15.87
$16.66
52-Week Range
$15.87
$34.52
Volume
6,516,284
50D / 200D Avg
$19.69
/
$22.59
Prev Close
$16.67
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.6 | 0.2 |
| P/B | 1.3 | 2.8 |
| ROE % | -14.6 | 3.7 |
| Net Margin % | -8.5 | 3.9 |
| Rev Growth 5Y % | -1.9 | 9.7 |
| D/E | 1.6 | 0.2 |
Analyst Price Target
Hold
$19.75
+23.7%
Low: $15.00
High: $25.00
Forward P/E
8.90
Forward EPS
$1.92
EPS Growth (est.)
+0.0%
Est. Revenue
11.36B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$2.40
$2.36 – $2.43
|
11.95B | 1 |
| FY2027 |
$2.04
$1.93 – $2.27
|
11.63B | 10 |
| FY2026 |
$1.92
$1.84 – $2.03
|
11.36B | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | $0.54 | $0.44 | -17.9% |
| 2025-10-30 | $0.60 | $0.69 | +15.0% |
| 2025-07-31 | $0.60 | $0.59 | -1.7% |
| 2025-05-01 | $0.48 | $0.55 | +13.8% |
| 2025-02-20 | $0.53 | $0.58 | +9.8% |
| 2024-11-08 | $0.78 | $0.80 | +2.6% |
| 2024-08-06 | $0.66 | $0.68 | +2.7% |
| 2024-05-02 | $0.61 | $0.65 | +7.1% |
Dividend History
7 yr streakYield
0.04%
Payout Ratio
-0.36%
Growth (3Y)
-23.25%
Growth (5Y)
-11.45%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 27, 2026 | Apr 01, 2026 | $0.01 | 1.77% |
| Nov 28, 2025 | Jan 02, 2026 | $0.01 | 2.77% |
| Aug 29, 2025 | Oct 01, 2025 | $0.17 | 2.75% |
| May 30, 2025 | Jul 01, 2025 | $0.17 | 2.62% |
| Feb 28, 2025 | Apr 01, 2025 | $0.17 | 2.67% |
| Nov 29, 2024 | Jan 02, 2025 | $0.17 | 3.09% |
| Aug 30, 2024 | Oct 01, 2024 | $0.29 | 3.06% |
| May 31, 2024 | Jul 01, 2024 | $0.29 | 3.40% |
| Feb 29, 2024 | Apr 01, 2024 | $0.29 | 2.83% |
| Nov 30, 2023 | Jan 02, 2024 | $0.29 | 3.22% |
| Aug 31, 2023 | Oct 02, 2023 | $0.29 | 2.86% |
| Jun 01, 2023 | Jul 03, 2023 | $0.29 | 2.81% |
| Feb 23, 2023 | Apr 03, 2023 | $0.29 | 2.86% |
| Dec 01, 2022 | Jan 03, 2023 | $0.29 | 2.20% |
| Sep 01, 2022 | Oct 03, 2022 | $0.29 | 2.01% |
| Jun 02, 2022 | Jul 01, 2022 | $0.29 | 1.52% |
| Feb 24, 2022 | Apr 01, 2022 | $0.28 | 1.32% |
| Dec 02, 2021 | Jan 03, 2022 | $0.28 | 1.42% |
| Sep 02, 2021 | Oct 01, 2021 | $0.28 | 1.30% |
| Jun 03, 2021 | Jul 01, 2021 | $0.28 | 1.24% |
Key Takeaways
Revenue declined -1.91% annually over 5 years
Generating 323.00M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.63%
Capital efficient — spends only 4.64% of revenue on capex
Growth
Revenue Growth (5Y)
-1.91%
Revenue (1Y)5.72%
Earnings (1Y)N/A
FCF Growth (3Y)-49.96%
Quality
Return on Equity
-14.62%
ROIC-1.43%
Net Margin-8.51%
Op. Margin-2.74%
Safety
Debt / Equity
1.63
Current Ratio2.31
Interest Coverage-1.06
Valuation
P/E Ratio
-8.59
Forward P/E8.90
P/B Ratio1.34
EV/EBITDAN/A
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.72% | Revenue Growth (3Y) | 4.18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1.91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 11.24B | Net Income (TTM) | -957.00M |
| ROE | -14.62% | ROA | -4.77% |
| Gross Margin | 30.05% | Operating Margin | -2.74% |
| Net Margin | -8.51% | Free Cash Flow (TTM) | 323.00M |
| ROIC | -1.43% | FCF Growth (3Y) | -49.96% |
| Safety | |||
| Debt / Equity | 1.63 | Current Ratio | 2.31 |
| Interest Coverage | -1.06 | ||
| Dividends | |||
| Dividend Yield | 0.04% | Payout Ratio | -0.36% |
| Dividend Growth (3Y) | -23.25% | Dividend Growth (5Y) | -11.45% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | -8.59 | Forward P/E | 8.90 |
| P/B Ratio | 1.34 | P/S Ratio | 0.73 |
| PEG Ratio | -0.27 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 20.72 |
| Forward P/S | 0.72 | Fwd Earnings Yield | 11.24% |
| FCF Yield | 3.93% | ||
| Market Cap | 8.22B | Enterprise Value | 16.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.24B | 10.64B | 10.36B | 10.06B | 12.15B |
| Net Income | -957.00M | -649.00M | 2.66B | -2.43B | 1.28B |
| EPS (Diluted) | -1.75 | -1.27 | 5.23 | -4.83 | 2.53 |
| Gross Profit | 3.38B | 3.98B | 4.15B | 3.55B | 4.72B |
| Operating Income | -308.00M | 14.00M | 707.00M | -2.85B | 1.35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20.06B | 25.78B | 28.28B | 28.29B | 33.52B |
| Total Liabilities | 13.95B | 18.76B | 19.81B | 22.39B | 24.40B |
| Shareholders' Equity | 6.13B | 6.96B | 8.40B | 5.83B | 9.08B |
| Total Debt | 10.00B | 13.45B | 14.11B | 17.20B | 18.31B |
| Cash & Equivalents | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B |
| Current Assets | 6.87B | 8.85B | 9.60B | 8.01B | 8.87B |
| Current Liabilities | 2.97B | 6.51B | 6.50B | 4.75B | 4.24B |